DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Aderis Pharmaceuticals
Aderis Pharmaceuticals
Federal Register/Vol. 70, No. 141/Monday, July 25, 2005/Notices
Patentes, Desenhos Industriais, Contratos, Programas De Computador, Indicações Geográficas, Topografia De Circuito Integrado
SCHEDULE 14A (RULE 14A-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(A) of the Securities Exchange Act of 1934 (Amendment No
The Influence of Organizational Capacity and Environmental Dynamism on the First Move–Performance Relationship Vera L
(12) Patent Application Publication (10) Pub. No.: US 2012/0157420 A1 Schneider (43) Pub
UR-Coeus Sponsor List
Biotechnology and Drug Discovery: from Bench to Bedside
FOIA Request & Response
SCHEDULE 14A (RULE 14A-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(A) of the Securities Exchange Act of 1934 (Amendment No
Academy Centennial Fund Academy Funds Acon Investments
Colleges and Universities, Teaching Hospitals, and Biotechnology Companies
List of Section 13F Securities, Second Quarter 2002
Diretoria De Patentes
Diretoria De Patentes
IPO Boom Likely in 2004
Singapore's Biomedical Science Sector Development Strategy
US Venture Capital Firms A
King Pharmaceuticals
Top View